Lagoda Investment Management, L.P. Seagen Inc. Transaction History

Lagoda Investment Management, L.P.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$191.51 - $216.16 $12,448 - $14,050	-65 Reduced 0.18%	36,850 $7.82 Million
Q2 2023 Aug 14, 2023	BUY	$187.64 - $206.25 $69,426 - $76,312	370 Added 1.01%	36,915 $7.1 Million
Q1 2023 May 15, 2023	SELL	$127.59 - $203.08 $229,662 - $365,544	-1,800 Reduced 4.69%	36,545 $7.4 Million
Q4 2022 Feb 14, 2023	SELL	$117.37 - $139.17 $1.13 Million - $1.34 Million	-9,610 Reduced 20.04%	38,345 $4.93 Million
Q3 2022 Nov 14, 2022	SELL	$135.27 - $180.11 $203,581 - $271,065	-1,505 Reduced 3.04%	47,955 $6.56 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $644,699 - $1.06 Million	-5,925 Reduced 10.7%	49,460 $8.75 Million
Q1 2022 May 16, 2022	SELL	$119.61 - $157.85 $487,051 - $642,765	-4,072 Reduced 6.85%	55,385 $7.98 Million
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $36,925 - $49,432	259 Added 0.44%	59,457 $9.19 Million
Q3 2021 Nov 15, 2021	SELL	$142.45 - $169.82 $82,905 - $98,835	-582 Reduced 0.97%	59,198 $10.1 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $41,199 - $49,135	305 Added 0.51%	59,780 $9.44 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $8.18 Million - $11.3 Million	59,475 New	59,475 $8.26 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Lagoda Investment Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Lagoda Investment Management, L.P. with notifications on news.